STEVEN ORTELL: Open Payments
NPI 1932126380 · ELKHORN, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$16,615 in 97 payments from 9 companies in 2025. Trend: 2023 $209 · 2024 $533 · 2025 $16,615
Consulting: $7,015Speaker / faculty: $6,662Food & beverage: $1,683Travel & lodging: $1,143Education: $113
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 29 | $11,033 |
| Otsuka America Pharmaceutical, Inc. | 6 | $4,502 |
| Neurocrine BioSciences, Inc. | 12 | $234 |
| Alkermes, Inc. | 15 | $227 |
| Teva Pharmaceuticals USA, Inc. | 10 | $194 |
| Vanda Pharmaceuticals Inc. | 7 | $177 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $162 |
| Lundbeck LLC | 2 | $50 |
| Janssen Pharmaceuticals, Inc | 2 | $36 |
Products named: ABILIFY MAINTENA, COBENFY, INGREZZA, ARISTADA, FANAPT, CAPLYTA, UZEDY, ABILIFY ASIMTUFII.
Industry payments across WI — which companies pay providers there.
